← Open Payments lookup

MAGDALENA DAWSON: Open Payments

NPI 1235610031 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$576 in 30 payments from 14 companies in 2025. Trend: 2023 $647 · 2024 $1,575 · 2025 $576

Food & beverage: $576
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.2$148
Fresenius USA Marketing, Inc.4$64
Bayer Healthcare Pharmaceuticals Inc.4$64
Otsuka America Pharmaceutical, Inc.3$44
OPKO Pharmaceuticals, LLC2$38
ANI Pharmaceuticals, Inc.2$36
AKEBIA THERAPEUTICS INC2$32
Travere Therapeutics, Inc.5$28
Novartis Pharmaceuticals Corporation1$27
Takeda Pharmaceuticals U.S.A., Inc.1$22

Products named: TARPEYO, VELPHORO, Kerendia, JYNARQUE, RAYALDEE, PURIFIED CORTROPHIN GEL, Vafseo, Vanrafia.

Industry payments across IA — which companies pay providers there.